You are here

PhRMA

After IRA, Minnesota's drug affordability proposal draws PhRMA's ire

After IRA, Minnesota's drug affordability proposal draws PhRMA's ire

Fierce Pharma

Inflation Reduction Act

Flag link:

AstraZeneca is third member to leave PhRMA in five months

AstraZeneca is third member to leave PhRMA in five months

Stat

Flag link:

Pharma is clearly not done fighting drug-pricing reforms

Pharma is clearly not done fighting drug-pricing reforms

Medical Marketing and Media

Inflation Reduction Act

Flag link:

PhRMA-backed alliance says it wants to 'modernize' the 340B program. Critics say the changes will only limit access

PhRMA-backed alliance says it wants to 'modernize' the 340B program. Critics say the changes will only limit access

Endpoints

Flag link:

PhRMA official discusses legislative priorities, lessons from the pandemic

PhRMA official discusses legislative priorities, lessons from the pandemic

RAPS.org

Flag link:

PBM trade group ad campaign hits back at drugmakers over prescription drug prices

PBM trade group ad campaign hits back at drugmakers over prescription drug prices

Medical Marketing and Media

Flag link:

DC court overrules PhRMA's bid to shut down drug imports from Canada

DC court overrules PhRMA's bid to shut down drug imports from Canada

Endpoints

drug importation

Flag link:

After AbbVie, Teva walks away from influential trade group PhRMA

After AbbVie, Teva walks away from influential trade group PhRMA

Fierce Pharma

Teva Pharmaceutical

Flag link:

Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback

Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback

Fierce Pharma

Inflation Reduction Act

small molecule drugs

Flag link:

Biotech pipeline hosts 163 potential meds for mental illness, with depression dominating: PhRMA

Biotech pipeline hosts 163 potential meds for mental illness, with depression dominating: PhRMA

Fierce Biotech

Flag link:

AbbVie leaves PhRMA, BIO: reports

AbbVie leaves PhRMA, BIO: reports

Medical Marketing and Media

Flag link:

Major drug price reforms head for Biden's signature as PhRMA weighs legal options

Major drug price reforms head for Biden's signature as PhRMA weighs legal options

Endpoints

Flag link:

With sotrovimab in the balance, Biogen vet reunites with George Scangos at Vir; First woman to chair PhRMA has more in store at Takeda

With sotrovimab in the balance, Biogen vet reunites with George Scangos at Vir; First woman to chair PhRMA has more in store at Takeda

Endpoints

Vir Biotechnology

Johanna Friedl-Naderer

Flag link:

Time for change: PhRMA survey shows insurance creates barriers to healthcare in US

Time for change: PhRMA survey shows insurance creates barriers to healthcare in US

Pharmaforum

Flag link:

Dueling 7-figure ad campaigns set sights on a big drug price negotiation bill coming soon

Dueling 7-figure ad campaigns set sights on a big drug price negotiation bill coming soon

Endpoints

patient advocacy groups

Flag link:

PhRMA calls for FDA to address unique needs of biosimilar review program

PhRMA calls for FDA to address unique needs of biosimilar review program

Biopharma Reporter

capacity planning adjustment

Flag link:

Budget proposal to allow Medicare to negotiate prices should 'enrage' seniors, PhRMA says

Budget proposal to allow Medicare to negotiate prices should 'enrage' seniors, PhRMA says

Fierce Pharma

Flag link:

Recent Developments in the Medicaid Drug Rebate Program

Recent Developments in the Medicaid Drug Rebate Program

FDA Law Blog

Flag link:

PhRMA’s new message to Washington: Don’t take us for granted

PhRMA’s new message to Washington: Don’t take us for granted

Stat

Flag link:

J&J scores backing from Chamber of Commerce, PhRMA and more in Supreme Court appeal of $2.1B talc verdict

J&J scores backing from Chamber of Commerce, PhRMA and more in Supreme Court appeal of $2.1B talc verdict

Fierce Pharma

Flag link:

Pages